A critical discovery in cancer research is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This essential cancer inhibitor protein is frequently inactivated in various types of tumors, causing https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research